About ZNA Middelheim
"ZNA Middelheim is het grootste algemeen ziekenhuis van Antwerpen. Het ziekenhuis is actief in zowat alle medische domeinen. ZNA Middelheim biedt de meest diverse technische en bloedonderzoeken. Je kan er onze specialisten raadplegen in de polikliniek, opgenomen worden in het ziekenhuis of een behandeling krijgen in het dagziekenhuis."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
30
Pfizer
8
Janssen Research & Development, LLC
7
Elixir Medical Corporation
6
Hoffmann-La Roche
6
Universitaire Ziekenhuizen KU Leuven
6
Abbott Medical Devices
4
Boston Scientific Corporation
4
Biotronik AG
3
Celgene
3
Neovasc Inc.
3
Clinical Trials at ZNA Middelheim
During the past decade, ZNA Middelheim conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 35 clinical trials were completed, i.e. on
average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 15 clinical trials were completed. i.e. 53.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
1989-09-01
Active, not recruiting
615
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
1993-03-01
Completed
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
1993-11-01
Unknown status
1,520
Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
1994-12-01
Completed
640
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
1995-08-01
Completed
392
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
1995-10-01
Unknown status
750
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
1996-03-01
Completed
320
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ZNA Middelheim" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 30 trials, followed by "Pfizer" with 8 trials
sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Elixir Medical Corporation" with 6 trials sponsored and "Hoffmann-La Roche"
with 6 trials sponsored. Other sponsors include 141 different institutions and
companies that sponsored additional 113 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ZNA Middelheim"
#1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Universiteit Antwerpen" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator. Other collaborators include 100 different institutions and companies that were
collaborators in the rest 99 trials.
Clinical Trials Conditions at ZNA Middelheim
According to Clinical.Site data, the most researched conditions in "ZNA Middelheim" are
"Coronary Artery Disease" (22 trials), "Atrial Fibrillation" (11 trials), "Leukemia" (9 trials), "Myelodysplastic Syndromes" (9 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "ZNA Middelheim" in a lesser frequency.
Clinical Trials Intervention Types at ZNA Middelheim
Most popular intervention types in "ZNA Middelheim" are "Drug" (115 trials), "Device" (58 trials), "Procedure" (26 trials), "Radiation" (20 trials) and "Biological" (16 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (22 trials), "radiation therapy" (15 trials), "cytarabine" (8 trials), "cisplatin" (7 trials) and "allogeneic bone marrow transplantation" (6 trials). Other intervention names were less common.
Clinical Trials Genders at ZNA Middelheim
The vast majority of trials in "ZNA Middelheim" are
180 trials for "All" genders, 12 trials for "Male" genders and 11 trials for "Female" genders.
Clinical Trials Status at ZNA Middelheim
Currently, there are 57 active trials in "ZNA Middelheim".
1 are not yet recruiting,
30 are recruiting,
25 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 97 completed trials in ZNA Middelheim,
undefined suspended trials,
and 27 terminated clinical trials to date.
Out of the total trials that were conducted in ZNA Middelheim, 2 "Phase 1"
clinical trials were conducted, 38 "Phase 2" clinical
trials and 83 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 47 trials that are defined as “Not Applicable".